How microdosing GLP-1 drugs became a longevity craze
Expert Opinions Vary: Some experts see potential benefits, while others urge caution until more specific studies are completed
Most clinical guidelines suggest that there is no direct contraindication for using semaglutide in patients with common, benign (non-cancerous) thyroid conditions like hypothyroidism or Hashimotos disease
Experts say that there are several reasons why people using semaglutide might want to microdose, some more legitimate than others
Certain pre-existing conditions require careful monitoring, as this medication could potentially worsen them
Meanwhile, Latin America accounts for 8.2% of global market share, with Brazil, Mexico, and Colombia serving as primary growth markets where diabetes prevalence continues accelerating amid expanding healthcare infrastructure